ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.
Ibrahim M, Parry S, Wilkinson D, Bilbe N, Allen D, Forrest S, Maxwell P, O'Grady A, Starczynski J, Tanier P, Gosney J, Kerr K, Miller K, Thunnissen E.
Ibrahim M, et al.
J Thorac Oncol. 2016 Dec;11(12):2241-2247. doi: 10.1016/j.jtho.2016.07.012. Epub 2016 Jul 25.
J Thorac Oncol. 2016.
PMID: 27468935
Free article.